(Q52524567)

2 May 2018

title

Agonist-activated alphavbeta3 on platelets and lymphocytes binds to the matrix protein osteopontin. (English)

1 reference

2 May 2018

author name string

J S Bennett

1

1 reference

2 May 2018

C Chan

2

1 reference

2 May 2018

G Vilaire

3

1 reference

2 May 2018

S A Mousa

4

1 reference

2 May 2018

W F DeGrado

5

1 reference

2 May 2018

language of work or name

English

0 references

publication date

1 March 1997

1 reference

2 May 2018

Journal of Biological Chemistry

published in

1 reference

2 May 2018

volume

272

1 reference

2 May 2018

issue

13

1 reference

2 May 2018

page(s)

8137-8140

1 reference

2 May 2018

Structural biology of glycoprotein IIb-IIIa.

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

High expression of genes for calcification-regulating proteins in human atherosclerotic plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

Exposure of platelet fibrinogen receptors by ADP and epinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

A colorimetric method for the measurement of platelet adhesion in microtiter plates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

Vitronectin and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

Comparison of cDNA-derived protein sequences of the human fibronectin and vitronectin receptor alpha-subunits and platelet glycoprotein IIb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

The amino-terminal one-third of alpha IIb defines the ligand recognition specificity of integrin alpha IIb beta 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

Ca2+ suppresses cell adhesion to osteopontin by attenuating binding affinity for integrin alpha v beta 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

Agonist-stimulated ligand binding by the platelet integrin alpha IIb beta 3 in a lymphocyte expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

Effect of cytoplasmic domain mutations on the agonist-stimulated ligand binding activity of the platelet integrin alphaIIbbeta3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.13.8137

21 January 2018

Identifiers

DOI

10.1074/JBC.272.13.8137

1 reference

2 May 2018

PubMed ID

9079626

1 reference

2 May 2018